Pharmalot... Pharmalittle... Good Morning

Rise and shine, everyone, the middle of the week is here. This offers us the opportunity to ask whether the proverbial glass is half full or half empty? While you ponder your preference, we are brewing another iced glass of stimulation, since the steam is already rising here on the Pharmalot corporate campus. Meanwhile, here are some tidbits. Have a smashing day, stay cool and stay in touch. Again, we would like to remind you that we accept classified information... Teva Discloses CEO Pay After Settling Lawsuit (Globes) Novartis Raises Forecasts Thanks To Lack Of Generic Diovan (Bloomberg News) Roche And Novartis Say Not Contacted By China As Part Of Probe (Reuters) Pfizer Licenses Out Tuberculosis Drug To Sequella (Pharma Times) Diabetes Drugs May Protect The Brain (Health Day News) BTG Halts Production At Facility Hit With Warning Letter (InPharma Technologist) EDITOR'S NOTE: Please check this post for additional stories during the day Read more
Source: Pharmalot - Category: Pharma Commentators Authors: Source Type: blogs